LSPN925
LSPN925 is an anticancer agent. LSPN925 exhibits cytotoxic and antiproliferative activities against tumor cells. LSPN925 has predicted oral bioavailability, low risks of hepatotoxicity and acute toxicity, and no risk of cardiotoxicity. LSPN925 can be used for the research of ovarian cancer, melanoma and breast cancer.
For research use only. We do not sell to patients.
- Formula: C24H22N2O6
- Molecular Weight:434.44
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
LSPN925 (48 h) inhibits the viability of A2780, A375 and MCF-7 cancer cells[1].
LSPN925 (48 h) alters the morphology and reduces the viability of A2780 ovarian cancer cells, as evidenced by increased membrane damage and decreased cell density[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:A2780 ovarian cancer cells, A375 human melanoma cells, MCF-7 breast cancer cells, MRC-5 non-cancerous lung cells
-
Concentration:/
-
Incubation Time:48 h
-
Result:Exhibited dose-dependent cytotoxicity against A2780, A375, and MCF-7 cancer cell lines, with IC50 values of 29.59 μM, 65.15 μM, and 81.20 μM, respectively.
Showed no significant cytotoxicity in non-cancerous MRC-5 cells (IC50 > 100 μM).
Chemical Information
-
Molecular Weight 434.44
-
Formula C24H22N2O6
-
SMILES
CC1=CC=C(OC(C(C(N2)=C(C(OCC)=O)C(C3=CC(OC)=CC=C3)NC2=O)=C4)=O)C4=C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)